Emsam (selegiline) will be the first PATCH for depression

April 2006

Emsam (selegiline) will be the first PATCH for depression.

It'll be used by psychiatrists as an alternative to oral MAO inhibitors...in patients who don't respond to other antidepressants. There's no proof yet it's effective in Parkinson's patients.

ORAL selegiline is selective for MAO-B at the low dose used for Parkinson's...but it's nonselective at higher doses used for depression.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote